Pfizer’s COVID-19 vaccine

India approves the urgent appeal made by Pfizer’s COVID-19 vaccine?

Follow Us:

Pfizer’s COVID-19 vaccine:

Pfizer’s COVID-19 vaccine Applied for the emergency use authorization of its coronavirus vaccine in India. It is the first company to do so as India is the second-highest number of infections in the world. The recently approved Britain vaccine approached Indian authorities on Saturday. VK Paul said on Saturday, “We welcome interest from Pfizer to seek emergency licensure in our country.” 

Paul also said that generally, the drug regulator of India takes nearly up to 90 days to decide on such applications. Nevertheless, it is expected that a conclusion on Pfizer’s vaccine could come much faster than that. 

The vaccines developed by Pfizer and Moderna might not be available in large quantities, said Paul in November. 

In a fight to control the Coronavirus, India hopes for the inclusion of five locally-tested vaccines. These vaccines mainly include the ones developed by AstraZeneca and Oxford University.

India’s climate challenging for the storage of Pfizer vaccine?

Industry experts have stated that despite there being some old storage facilities in India, the Pfizer shot might find it a bit difficult in the Indian circumstances for its storage. Since, the Pfizer shot needs to be stored at minus 70 degrees Celsius (-94 F) or below, the storage is supposed to be grim in the Indian environment.

India has reported more than 9.57 million COVID-19 cases that made India the world’s second-highest after the United States with approximately 140,000 deaths.

About Pfizer 

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The main aim of the company is to engage in the discovery, development, and manufacture of healthcare products. The organization manages the commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The development and commercialization of vaccines and medicines are done by IH. Moreover, EH focuses on the therapeutic areas that surround internal medicine, vaccines, oncology, inflammation and immunology, rare diseases, and consumer healthcare. The research and development (R&D) organization, as well as the contract manufacturing business, are also managed by EH.

Picture of BusinessApac


BusinessApac shares the latest news and events in the business world and produces well-researched articles to help the readers stay informed of the latest trends. The magazine also promotes enterprises that serve their clients with futuristic offerings and acute integrity.

Subscribe To Our Newsletter

Get updates and learn from the best

About Us

West has been driving the business world owing to its developed economies. The leading part of the world is straining to sustain its dominance. However, the other parts of the world, especially Asia Pacific region have been displaying escalating growth in terms of business and technological advancements.

Copyright © 2022 - Business APAC. All Right Reserved.

Scroll to Top

Hire Us To Spread Your Content

Fill this form and we will call you.